chr14-75091436-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_033116.6(NEK9):​c.2276G>A​(p.Gly759Asp) variant causes a missense change. The variant allele was found at a frequency of 0.000000688 in 1,454,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G759S) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

NEK9
NM_033116.6 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.69

Publications

0 publications found
Variant links:
Genes affected
NEK9 (HGNC:18591): (NIMA related kinase 9) This gene encodes a member of the NimA (never in mitosis A) family of serine/threonine protein kinases. The encoded protein is activated in mitosis and, in turn, activates other family members during mitosis. This protein also mediates cellular processes that are essential for interphase progression. [provided by RefSeq, Jul 2016]
ZC2HC1C (HGNC:20354): (zinc finger C2HC-type containing 1C) Predicted to enable metal ion binding activity. [provided by Alliance of Genome Resources, Apr 2022]
ZC2HC1C Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.20337123).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEK9NM_033116.6 linkc.2276G>A p.Gly759Asp missense_variant Exon 19 of 22 ENST00000238616.10 NP_149107.4 Q8TD19Q6PKF2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEK9ENST00000238616.10 linkc.2276G>A p.Gly759Asp missense_variant Exon 19 of 22 1 NM_033116.6 ENSP00000238616.5 Q8TD19

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.88e-7
AC:
1
AN:
1454084
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
722916
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33360
American (AMR)
AF:
0.00
AC:
0
AN:
44250
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25532
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39654
South Asian (SAS)
AF:
0.0000118
AC:
1
AN:
84898
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52990
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4724
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1108632
Other (OTH)
AF:
0.00
AC:
0
AN:
60044
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.375
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 05, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2276G>A (p.G759D) alteration is located in exon 19 (coding exon 19) of the NEK9 gene. This alteration results from a G to A substitution at nucleotide position 2276, causing the glycine (G) at amino acid position 759 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.098
BayesDel_addAF
Benign
-0.014
T
BayesDel_noAF
Benign
-0.26
CADD
Benign
16
DANN
Uncertain
0.99
DEOGEN2
Benign
0.058
T
Eigen
Benign
-0.38
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.40
N
LIST_S2
Benign
0.68
T
M_CAP
Benign
0.065
D
MetaRNN
Benign
0.20
T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
1.0
L
PhyloP100
3.7
PrimateAI
Benign
0.41
T
PROVEAN
Benign
0.060
N
REVEL
Benign
0.21
Sift
Benign
0.037
D
Sift4G
Benign
0.082
T
Polyphen
0.42
B
Vest4
0.41
MutPred
0.29
Gain of solvent accessibility (P = 0.1583);
MVP
0.76
MPC
0.61
ClinPred
0.55
D
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.13
gMVP
0.45
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr14-75558139; API